miRecule

Early-stage biotechnology company developing RNA-based therapeutics

Company details
Company
miRecule
Stage
Seed

About

miRecule

miRecule develops next-generation RNA therapeutics to treat a variety of diseases including cancer and muscular dystrophy.

Our portfolio

Boutique Venture Partners backs authentic founders who transform industries and create new ones in healthcare and life sciences.